| MeSH term | MeSH ID | Detail |
|---|---|---|
| Stomach Ulcer | D013276 | 75 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Breast Neoplasms | D001943 | 24 associated lipids |
| Neoplasms | D009369 | 13 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Vanheel B and Van de Voorde J | Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. | 2001 | J. Pharmacol. Exp. Ther. | pmid:11160613 |
| MacCarrone M et al. | Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. | 2001 | Eur. J. Biochem. | pmid:11168423 |
| Di Marzo V et al. | Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11181068 |
| Palkovits M | [The brain and the pain: neurotransmitters and neuronal pathways of pain perception and response]. | 2000 | Orv Hetil | pmid:11184247 |
| Maccarrone M and Finazzi-Agró A | Platelet activation: a new vascular activity of anandamide. | 2000 | FEBS Lett. | pmid:11184253 |
| Maccarrone M et al. | Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. | 2001 | J. Neurochem. | pmid:11208922 |
| Morefield SI et al. | Drug evaluations using neuronal networks cultured on microelectrode arrays. | 2000 | Biosens Bioelectron | pmid:11219752 |
| Tucker RC et al. | The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. | 2001 | Br. J. Pharmacol. | pmid:11226144 |
| Maingret F et al. | The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. | 2001 | EMBO J. | pmid:11226154 |
| Matias I et al. | Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis. | 2001 | Brain Res. Mol. Brain Res. | pmid:11245916 |
| Izzo AA et al. | Effect of vanilloid drugs on gastrointestinal transit in mice. | 2001 | Br. J. Pharmacol. | pmid:11264233 |
| Kagota S et al. | 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. | 2001 | Eur. J. Pharmacol. | pmid:11275004 |
| Bisogno T et al. | The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. | 2001 | Eur. J. Biochem. | pmid:11277920 |
| De Petrocellis L et al. | The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. | 2001 | J. Biol. Chem. | pmid:11278420 |
| D'Souza DC and Kosten TR | Cannabinoid antagonists: a treatment in search of an illness. | 2001 | Arch. Gen. Psychiatry | pmid:11296092 |
| Mechoulam R and Fride E | Physiology. A hunger for cannabinoids. | 2001 | Nature | pmid:11298428 |
| Smart D et al. | Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. | 2001 | Eur. J. Pharmacol. | pmid:11301059 |
| Jacobsson SO and Fowler CJ | Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. | 2001 | Br. J. Pharmacol. | pmid:11309246 |
| Kim D and Thayer SA | Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. | 2001 | J. Neurosci. | pmid:11319244 |
| Fimiani C et al. | Antagonism of LPS and IFN-gamma induced iNOS expression in human atrial endothelia by morphine, anandamide, and estrogen. | 2000 | Acta Pharmacol. Sin. | pmid:11324436 |
| Kobayashi Y et al. | Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. | 2001 | J. Biochem. | pmid:11328586 |
| Chang YH et al. | Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. | 2001 | J. Cell. Biochem. | pmid:11329626 |
| Olah Z et al. | Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. | 2001 | J. Biol. Chem. | pmid:11333266 |
| Bueb JL et al. | Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. | 2001 | Biochim. Biophys. Acta | pmid:11336796 |
| Quistad GB et al. | Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. | 2001 | Toxicol. Appl. Pharmacol. | pmid:11350214 |
| Day TA et al. | Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. | 2001 | Mol. Pharmacol. | pmid:11353795 |
| Berger A et al. | Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11353819 |
| James JS | Marijuana and chocolate. | 1996 | AIDS Treat News | pmid:11363932 |
| Farquhar-Smith WP and Rice AS | Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. | 2001 | Anesthesiology | pmid:11374613 |
| Maccarrone M et al. | Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. | 2001 | J. Immunol. | pmid:11390466 |
| Wenger T et al. | The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11394887 |
| Holt S et al. | Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. | 2001 | Br. J. Pharmacol. | pmid:11399668 |
| Di Marzo V et al. | Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. | 2001 | Eur. J. Pharmacol. | pmid:11408034 |
| Breivogel CS et al. | Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. | 2001 | Mol. Pharmacol. | pmid:11408610 |
| Wang Y et al. | Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. | 2001 | Anal. Biochem. | pmid:11412008 |
| Boger DL et al. | alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. | 2001 | Bioorg. Med. Chem. Lett. | pmid:11412972 |
| De Petrocellis L et al. | The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. | 2001 | J. Neurochem. | pmid:11413249 |
| Calignano A et al. | Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. | 2001 | Eur. J. Pharmacol. | pmid:11426841 |
| Fride E et al. | Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. | 2001 | Eur. J. Pharmacol. | pmid:11426843 |
| Ugdyzhekova DS et al. | Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. | 2001 | Bull. Exp. Biol. Med. | pmid:11427912 |
| Di Marzo V et al. | Anandamide: some like it hot. | 2001 | Trends Pharmacol. Sci. | pmid:11431028 |
| Morisset V and Urban L | Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. | 2001 | J. Neurophysiol. | pmid:11431486 |
| Bátkai S et al. | Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. | 2001 | Nat. Med. | pmid:11433348 |
| Murillo-RodrÃguez E et al. | Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. | 2001 | Neuroreport | pmid:11447321 |
| Sprague J et al. | Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. | 2001 | Eur. J. Pharmacol. | pmid:11448475 |
| Wagner JA et al. | Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. | 2001 | Eur. J. Pharmacol. | pmid:11448486 |
| Porter AC and Felder CC | The endocannabinoid nervous system: unique opportunities for therapeutic intervention. | 2001 | Pharmacol. Ther. | pmid:11448725 |
| Laine K et al. | Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. | 2001 | Pharm. Res. | pmid:11451037 |
| Senior K | Endogenously produced cannabinoids and liver cirrhosis. | 2001 | Lancet | pmid:11454385 |
| Stanford SJ et al. | Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. | 2001 | Br. J. Pharmacol. | pmid:11454655 |